H1N1 Vaccines Recalled by AstraZeneca’s MedImmune Unit
AstraZeneca’s MedImmune unit has issued a recall on 4.7 million doses of their nasal spray vaccine for H1N1. The recall was voluntary from the company, and they claim that the cause was due to potency concerns, not a failure or defect…